Publikace
- Minimal Residual Disease-Based Risk Stratification in Chinese Childhood Acute Lymphoblastic Leukemia by Flow Cytometry and Plasma DNA Quantitative Polymerase Chain Reaction2013 | 2. lékařská fakulta
- Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis2011 | 2. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Detection of Residual B Precursor Lymphoblastic Leukemia by Uniform Gating Flow Cytometry2010 | 2. lékařská fakulta
- Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria2010 | 2. lékařská fakulta
- Interfant 99 - léčebná studie zohledňující odlišnou biologii akutní lymfoblastické leukemie kojenců a její výsledky v České republice2009 | 2. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | 2. lékařská fakulta
- B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL2008 | 2. lékařská fakulta
- Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia2024 | 2. lékařská fakulta
- Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study2024 | 2. lékařská fakulta
- CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment2024 | 2. lékařská fakulta
Loading network view...